<SEC-DOCUMENT>0001104659-20-004017-index.html : 20200115 <SEC-HEADER>0001104659-20-004017.hdr.sgml : 20200115 <ACCEPTANCE-DATETIME>20200114185747 ACCESSION NUMBER: 0001104659-20-004017 CONFORMED SUBMISSION TYPE: S-8 PUBLIC DOCUMENT COUNT: 7 FILED AS OF DATE: 20200115 DATE AS OF CHANGE: 20200114 EFFECTIVENESS DATE: 20200115 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ArTara Therapeutics, Inc. CENTRAL INDEX KEY: 0001359931 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 SEC ACT: 1933 Act SEC FILE NUMBER: 333-235918 FILM NUMBER: 20527028 BUSINESS ADDRESS: STREET 1: 1 LITTLE WEST 12TH STREET CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: 646-844-0337 MAIL ADDRESS: STREET 1: 1 LITTLE WEST 12TH STREET CITY: NEW YORK STATE: NY ZIP: 10014 FORMER COMPANY: FORMER CONFORMED NAME: PROTEON THERAPEUTICS INC DATE OF NAME CHANGE: 20060420 </SEC-HEADER> <DOCUMENT> <TYPE>S-8 <SEQUENCE>1 <FILENAME>a20-3439_1s8.htm <DESCRIPTION>S-8 <TEXT> Document 1 - file: a20-3439_1s8.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.9 <SEQUENCE>2 <FILENAME>a20-3439_1ex4d9.htm <DESCRIPTION>EX-4.9 <TEXT> Document 2 - file: a20-3439_1ex4d9.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>3 <FILENAME>a20-3439_1ex5d1.htm <DESCRIPTION>EX-5.1 <TEXT> Document 3 - file: a20-3439_1ex5d1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>4 <FILENAME>a20-3439_1ex23d1.htm <DESCRIPTION>EX-23.1 <TEXT> Document 4 - file: a20-3439_1ex23d1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.2 <SEQUENCE>5 <FILENAME>a20-3439_1ex23d2.htm <DESCRIPTION>EX-23.2 <TEXT> Document 5 - file: a20-3439_1ex23d2.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.2 <SEQUENCE>6 <FILENAME>a20-3439_1ex99d2.htm <DESCRIPTION>EX-99.2 <TEXT> Document 6 - file: a20-3439_1ex99d2.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>7 <FILENAME>g34391ksi001.gif <DESCRIPTION>GRAPHIC <TEXT> Document 7 - file: g34391ksi001.gif
</DOCUMENT> </SEC-DOCUMENT>